Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool have?
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool has 54 citations in the OpenAlex counts ScholarIQ stores.
When was Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool published?
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool has 2020 year in the ScholarIQ index.
What is the open-access status of Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool?
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool has bronze oa status in the ScholarIQ index.
What is the DOI of Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool?
The DOI for Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool is on the source record.
What is the PMID of Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool?
The PMID for Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool is on the source record.
What is the OpenAlex record for Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool?
The OpenAlex for Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool is on the source record.